Abstract
This randomized controlled study aimed to investigate the effects of art psychotherapy on moderate-to-severe major depressive disorder (MDD). Forty-two MDD patients were recruited from a psychiatric outpatient clinic in Seoul, the Republic of Korea. Participants were allocated on a randomized, open-label basis to either an experimental group, wherein they were treated with art psychotherapy added to pharmacotherapy, or a control group, wherein they were treated with pharmacotherapy alone. Pre- and post-test measures of the Hamilton Depression Rating Scale, Beck Depression Inventory-II, and remission rates were measured. The results indicate that patients treated with art psychotherapy and ongoing pharmacotherapy showed slightly greater improvement when compared with pharmacotherapy alone in moderate-to-severe MDD. These results suggest that art psychotherapy could be an effective add-on strategy for the treatment of moderate-to-severe MDD. However, a rigorous test would facilitate a better understanding of art psychotherapy as an add-on strategy for MDD treatment.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference51 articles.
1. Prevalence and correlates of major depressive disorder: A systematic review;Dunne;Rev. Bras. de Psiquiatr.,2020
2. Trivedi, M.H. (2020). Major Depressive Disorder in Primary Care: Strategies for Identification. J. Clin. Psychiatry, 81.
3. AFSP (2022, February 26). Suicide Risk Factors and Warning Signs. Available online: https://afsp.org/risk-factors-protective-factors-and-warning-signs#risk-factors.
4. CDCP (2022, February 26). Risk and Protective Factors, Available online: https://www.cdc.gov/suicide/factors/.
5. NIMH (2022, February 26). Suicide Prevention, Available online: https://www.nimh.nih.gov/health/topics/suicide-prevention#part_153178.